Samir Mitragotri, Ph.D. Department of Chemical Engineering University of California, Santa Barbara, CA 93106 Ph: 805-893-7532, Email: [email protected] Web site: http://drugdelivery.engr.ucsb.edu/ Education Ph.D. 1996 Massachusetts Institute of Technology, Chemical Engineering, Cambridge, MA B.S. 1992 University of Bombay (ICT), Chemical Engineering, Mumbai, INDIA Summary of Research Interests and Expertise Prof. Mitragotri has made groundbreaking contributions to the field of drug delivery. His research has advanced fundamental understanding of biological barriers and has led to the development of new materials as well as technologies for diagnosis and treatment of various ailments including diabetes, cardiovascular diseases, skin diseases and infectious diseases, among others. Many of his technologies have advanced to human clinical studies and products. At the same time, fundamental understanding developed through his research has advanced the understanding of the biology of barriers in the human body. His research has made particular impact on the following areas: Skin and Transdermal drug delivery: Prof. Mitragotri has established a fundamental knowledge base of transport properties of skin. He also developed mathematical models of skin permeation and analytical tools to study biophysics of skin structure-function relationship (PNAS 2005). Further, he has developed novel technologies to enable transdermal delivery of proteins, peptides and siRNA which otherwise have to be injected using needles. He has pioneered a large number of technologies including low-frequency ultrasound, pulsed microjet injector, high throughput skin experimentation, skin penetrating peptides and ionic liquids for transdermal delivery of proteins, peptides and nucleic acids. Professor Mitragotri’s research has made it possible to painlessly deliver macromolecules using transdermal patches, which was previously considered not feasible. He pioneered an ultrasound-based technique to deliver insulin and vaccines through the skin (FDA-approved product for delivering local anesthesia, and human clinical trials for nanoparticle delivery for treating acne). He also developed an ultrasound-based method to harvest skin’s fluid for non-invasive glucose montoring in diabetic patients (product in late clinical trials). Using ultrasound and a novel surfactant blend, he developed a method to solubilize tissues without protein denaturation, a finding he used for non-invasive diagnostics of allergies (PNAS 2010). First product based on this core technology is currently marketed. Prof. Mitragotri was first to apply combinatorial discovery approaches for transdermal delivery (Nat. Biotech. 2004). He invented a tool (INSIGHT) that allowed, for the first time, discovery of rare formulations to deliver macromolecules (technique now used in industry for discovery of topical formulations). Recently, Prof. Mitragotri discovered a novel peptide, designed for the first time, to simultaneously enhance delivery of siRNA across the skin barrier and cell membranes for the treatment of various skin disorders (PNAS 2011) (technology validated in human clinical study for hyaluronic acid delivery). He also designed a novel ionic liquid as a broad spectrum topical antibiotic effective against bacteria, viruses and fungi, and simultaneously capable of delivering drugs into skin (PNAS 2014). 1 Intestine and Oral drug delivery: Prof. Mitragotri has developed fundamental understanding of trans- epithelial transport in the intestine. He has also established an understanding of the effect of penetration enhancers on permeation across the intestinal epithelium (Pharm Res., 2008). Further, he developed novel technologies, in particular intestinal patches, for oral delivery of proteins such as insulin and calcitonin (JCR, 2004, 2013). Immune System and Targeted drug delivery: Prof. Mitragotri has developed unique bio-inspired nanoparticles of novel physical, chemical and biological properties to understand the fundamental principles of body’s immune barrier (PNAS 2006, 2007, 2010, and 2013a). Using these particles, he also developed new technologies for the treatment of cancer and cardiovascular diseases (PNAS, 2013b). He developed novel particles that mimic red blood cells (PNAS, 2009) and platelets (ACS Nano, 2014); his platelet- mimicking particles, designed as potential therapeutic agents to stop bleeding in patients suffering from traumatic blood loss, performed well in preclinical models (ACS Nano, 2014). He has also developed hybrid systems that make use of synthetic nanoparticles hitchhiking on natural cells for targeted delivery of drugs (ACS Nano, 2013). Academic Appointments 07/07-present Professor, Department of Chemical Engineering, UCSB 14/07-present Professor, Technology Management Program, UCSB, affiliated faculty 13/7-present Duncan and Suzanne Mellichamp Chair in Systems Biology and Bioengineering 12/6-present Professor of Biology, College of Creative Studies, UCSB 11/01-present Founding Director, Center for Bioengineering, UCSB 07/07-present Professor, Biomolecular Science and Engineering, UCSB 13/10-15/06 Director, Translational Medicine Research Laboratories, UCSB 06/05-06/07 Associate Professor, Department of Chemical Engineering, UCSB 00/01-05/06 Assistant Professor, Department of Chemical Engineering, UCSB Other Current Appointments (university/academic) Founding Editor-in-Chief, Bioengineering & Translational Medicine, an AIChE and SBE journal (2015-present) Associate Editor, Journal of Controlled Release (2011-present) Scientific Advisory Board member, Wadhwani Research Center for Bioengineering, IIT Bombay (2015-present) NIH Gene and Drug Delivery Study Section member (2014-present) BioTAP (UCSB’s Technology Translation Program, Founder, co-Director) (2012-present) Annual Meeting Programming Committee (Controlled Release Society, 2016) International Advisory Board of the 11th International Conference "Medical Applications of Novel Biomaterials and Nanotechnology" of CIMTEC 2016 Editorial Boards of the following journals o Journal of Drug Targeting o Technology o Therapeutic Delivery o Experimental Medicine and Biology 2 o Cancer Nanotechnology o Journal of Laboratory Automation o Regenerative Engineering and Translational Medicine Other Current Appointments Pfizer Inc. (Technical Advisory Board member, 2014-present) L’Oreal (Scientific Advisory Board member, 2013-present) Entrega Inc. (Scientific Advisory Board member, 2011-present) EnduRx Inc (Scientific Advisory Board member, 2011-present) Skincential Biosciences (Board member, 2010-present) Liquideon, LLC (Board member, 2016-present) CTX Technologies (Scientific Advisory Board, 2015-present) Awards and Honors 2016 Chair, Indo-US Frontiers of Engineering 2016 Tom Watson Memorial Lecturer, University of Sydney 2015 NR Kamath Chair Professor for Institutional Excellence, IIT Bombay 2015 Thomson Reuters Highly Cited Researcher 2015 Elected Fellow, American Association of Pharmaceutical Scientists (AAPS) 2015 Elected Fellow, Biomedical Engineering Society (BMES) 2015 Andreas Acrivos Professional Progress Award, AIChE 2015 Britton Chance Distinguished Lecture at University of Pennsylvania 2015 BMM award for Excellence in Science and Technology 2015 Distinguished Endowed Lectureship, Charotar Univ. of Science and Technology, India 2015 Elected Fellow, Controlled Release Society (CRS) 2015 Member, National Academy of Engineering (NAE) 2014 Elected Fellow, National Academy of Inventors (NAI) 2014 Distinguished Alumnus Award, Institute of Chemical Technology 2014 Distinguished Bioengineering Speaker, University of California, Riverside 2013 Bold Aspiration Lecturer, University of Kansas 2012 Elected Fellow, American Association of Advancement of Science (AAAS) 2012 AIChE area 15 Plenary award 2012 AIChE area 1c Plenary Speaker 2011 Edison award for innovation, Gold Medal 2010 Edison award for Innovation, Silver Medal 2009 Kothari Visiting Professor, Institute of Chemical Technology, Mumbai, India 2009 Elected Fellow, American Institute of Medical and Biological Engineering (AIMBE) 2009 Edison award for Innovation, Bronze Medal 2008 Controlled Release Society Young Investigator Award 2008 Alan MacDiarmid Best Paper Award in Interdisciplinary Research by Society of Experimental Biology and Medicine 2005 Allan P. Colburn Award by American Institute of Chemical Engineers 2004 Controlled Release Society Outstanding Pharmaceutical Research Award 2004 Hendrick C. Van Ness Award Lecturer, Rensselaer Polytechnic Institute 3 2004 Pfizer-Capsugel Award for Innovation in Oral Delivery 2004 Popular Science Best of new award 2003 Global Indus Technovator Award 2003 Chancellor’s Award for Excellence in Undergraduate Research 2001 Outstanding Faculty Award, UCSB 2001 Junior Faculty Research Incentive Award, UCSB 2001 3M Young faculty award 2001 Culpepper Biomedical Pilot Initiative award 2000 CRS-Dow Corning Outstanding Research Award 2000 International Research Promotion Council Young Scientist Award 1999 Technology Review Young Innovator Award (TR100) 1996 Harvard Health Letter top ten advances of the year 1995 Ebert Prize by the American Pharmaceutical Association Translation of Technologies from the Lab Prof. Mitragotri’s inventions are being/have been actively translated into clinical products. Ultrasound-mediated Transdermal Delivery (sonophoresis): Professor Mitragotri’s research in sonophoresis was translated by Sontra Inc., which developed and launched an ultrasonic drug delivery system (SonoPrepTM)